L. Licitra

发表

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

V. Grégoire, E. Felip, S. Leung, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results.

F. Baldanti, P. Pedrazzoli, F. Locatelli, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Non-surgical organ preservation strategies for locally advanced laryngeal tumors: what is the Italian attitude? Results of a national survey on behalf of AIRO and AIOM

L. Licitra, P. Franco, U. Ricardi, 2016, Medical Oncology.

Long-term update of the 24954 EORTC phase III trial on larynx preservation.

V. Grégoire, J. Vermorken, L. Barzan, 2016, European journal of cancer.

ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology—edition 2016

J. Bergh, S. Litière, E. Felip, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma

M. Kreissl, M. Schlumberger, M. Brose, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach.

J. Machiels, J. Bogaerts, I. Tinhofer, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study

J. Langendijk, G. Koutsodontis, É. Remenár, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Best practices in the management of the psycho-oncologic aspects of head and neck cancer patients: recommendations from the European Head and Neck Cancer Society Make Sense Campaign.

J. Bernier, W. Golusiński, L. Licitra, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study.

K. Ang, R. Miceli, F. Perrone, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

From chemoprevention and organ preservation programmes to postoperative management: major achievements and strategies of the EORTC Head and Neck Cancer Group.

J. Bernier, C. Debruyne, H. Langendijk, 2012, European journal of cancer.

Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck.

T. Gauler, A. Dietz, O. Hamid, 2013, European journal of cancer.

Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.

R. Miceli, F. Perrone, A. Gloghini, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

F. Caponigro, R. Miceli, G. Rinaldi, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982).

D. Lacombe, J. Bogaerts, J. Bernier, 2008, European journal of cancer.

Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow-up.

E. Felip, L. Licitra, L. Licitra, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.